Previous studies have shown that interleukin-33 (IL-33) is highly expressed in skin keratinocytes and endothelial cells, and its effect on the skin may be related to the early stage of skin inflammation [6] and AD. This evidence concerns the gene IL33 and Alzheimer disease.